237 related articles for article (PubMed ID: 28439013)
1. Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands.
Nakagawa H; Suzuki N; Hirata Y; Hikiba Y; Hayakawa Y; Kinoshita H; Ihara S; Uchino K; Nishikawa Y; Ijichi H; Otsuka M; Arita J; Sakamoto Y; Hasegawa K; Kokudo N; Tateishi K; Koike K
Proc Natl Acad Sci U S A; 2017 May; 114(19):E3806-E3815. PubMed ID: 28439013
[TBL] [Abstract][Full Text] [Related]
2. Mouse Model for Cholangiocarcinoma from Peribiliary Glands.
Nakagawa H; Suzuki N; Koike K
Methods Mol Biol; 2019; 1905():237-245. PubMed ID: 30536105
[TBL] [Abstract][Full Text] [Related]
3. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
4. Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer.
Nakagawa H; Hayata Y; Yamada T; Kawamura S; Suzuki N; Koike K
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895797
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
[TBL] [Abstract][Full Text] [Related]
6. L1 Cell Adhesion Molecule Promotes Migration and Invasion via JNK Activation in Extrahepatic Cholangiocarcinoma Cells with Activating
Kim H; Hwang H; Lee H; Hong HJ
Mol Cells; 2017 May; 40(5):363-370. PubMed ID: 28535665
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterisation of six human biliary tract cancer cell lines.
Ku JL; Yoon KA; Kim IJ; Kim WH; Jang JY; Suh KS; Kim SW; Park YH; Hwang JH; Yoon YB; Park JG
Br J Cancer; 2002 Jul; 87(2):187-93. PubMed ID: 12107841
[TBL] [Abstract][Full Text] [Related]
9. Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium.
Kinoshita H; Hayakawa Y; Konishi M; Hata M; Tsuboi M; Hayata Y; Hikiba Y; Ihara S; Nakagawa H; Ikenoue T; Ushiku T; Fukayama M; Hirata Y; Koike K
J Pathol; 2019 Jan; 247(1):35-47. PubMed ID: 30168144
[TBL] [Abstract][Full Text] [Related]
10. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells.
Yokomuro S; Tsuji H; Lunz JG; Sakamoto T; Ezure T; Murase N; Demetris AJ
Hepatology; 2000 Jul; 32(1):26-35. PubMed ID: 10869285
[TBL] [Abstract][Full Text] [Related]
11. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
12. Autophagy may occur at an early stage of cholangiocarcinogenesis via biliary intraepithelial neoplasia.
Sasaki M; Nitta T; Sato Y; Nakanuma Y
Hum Pathol; 2015 Feb; 46(2):202-9. PubMed ID: 25466963
[TBL] [Abstract][Full Text] [Related]
13. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.
Colyn L; Alvarez-Sola G; Latasa MU; Uriarte I; Herranz JM; Arechederra M; Vlachogiannis G; Rae C; Pineda-Lucena A; Casadei-Gardini A; Pedica F; Aldrighetti L; López-López A; López-Gonzálvez A; Barbas C; Ciordia S; Van Liempd SM; Falcón-Pérez JM; Urman J; Sangro B; Vicent S; Iraburu MJ; Prosper F; Nelson LJ; Banales JM; Martinez-Chantar ML; Marin JJG; Braconi C; Trautwein C; Corrales FJ; Cubero FJ; Berasain C; Fernandez-Barrena MG; Avila MA
J Exp Clin Cancer Res; 2022 May; 41(1):183. PubMed ID: 35619118
[TBL] [Abstract][Full Text] [Related]
14. Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.
Shimizu T; Yokomuro S; Mizuguchi Y; Kawahigashi Y; Arima Y; Taniai N; Mamada Y; Yoshida H; Akimaru K; Tajiri T
World J Gastroenterol; 2006 Oct; 12(39):6316-24. PubMed ID: 17072955
[TBL] [Abstract][Full Text] [Related]
15. PTEN loss and KRAS activation cooperate in murine biliary tract malignancies.
Marsh V; Davies EJ; Williams GT; Clarke AR
J Pathol; 2013 Jun; 230(2):165-73. PubMed ID: 23483557
[TBL] [Abstract][Full Text] [Related]
16. Regeneration of human extrahepatic biliary epithelium: the peribiliary glands as progenitor cell compartment.
Sutton ME; op den Dries S; Koster MH; Lisman T; Gouw AS; Porte RJ
Liver Int; 2012 Apr; 32(4):554-9. PubMed ID: 22171992
[TBL] [Abstract][Full Text] [Related]
17. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
[TBL] [Abstract][Full Text] [Related]
18. Axin2
Hayata Y; Nakagawa H; Kurosaki S; Kawamura S; Matsushita Y; Hayakawa Y; Suzuki N; Hata M; Tsuboi M; Kinoshita H; Miyabayashi K; Mizutani H; Nakagomi R; Ikenoue T; Hirata Y; Arita J; Hasegawa K; Tateishi K; Koike K
Gastroenterology; 2021 May; 160(6):2133-2148.e6. PubMed ID: 33465373
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas.
Tomita H; Tanaka K; Hirata A; Okada H; Imai H; Shirakami Y; Ohnishi K; Sugie S; Aoki H; Hatano Y; Noguchi K; Kanayama T; Niwa A; Suzui N; Miyazaki T; Tanaka T; Akiyama H; Shimizu M; Yoshida K; Hara A
Cell Rep; 2021 Feb; 34(8):108772. PubMed ID: 33626352
[TBL] [Abstract][Full Text] [Related]
20. KRAS mutation in intrahepatic cholangiocarcinoma: Linkage with metastasis-free survival and reduced E-cadherin expression.
Tanaka M; Kunita A; Yamagishi M; Katoh H; Ishikawa S; Yamamoto H; Abe J; Arita J; Hasegawa K; Shibata T; Ushiku T
Liver Int; 2022 Oct; 42(10):2329-2340. PubMed ID: 35833881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]